首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   582篇
  免费   16篇
  国内免费   4篇
化学   318篇
晶体学   3篇
力学   23篇
数学   68篇
物理学   190篇
  2023年   6篇
  2022年   7篇
  2021年   25篇
  2020年   21篇
  2019年   9篇
  2018年   10篇
  2017年   12篇
  2016年   26篇
  2015年   18篇
  2014年   11篇
  2013年   28篇
  2012年   56篇
  2011年   42篇
  2010年   34篇
  2009年   33篇
  2008年   32篇
  2007年   29篇
  2006年   28篇
  2005年   25篇
  2004年   17篇
  2003年   6篇
  2002年   8篇
  2001年   10篇
  2000年   11篇
  1999年   12篇
  1998年   10篇
  1997年   6篇
  1996年   4篇
  1995年   6篇
  1994年   7篇
  1993年   4篇
  1992年   5篇
  1991年   5篇
  1990年   3篇
  1988年   2篇
  1987年   3篇
  1986年   7篇
  1985年   2篇
  1984年   2篇
  1983年   3篇
  1982年   1篇
  1981年   2篇
  1979年   2篇
  1978年   1篇
  1977年   1篇
  1976年   2篇
  1974年   3篇
  1973年   2篇
  1970年   1篇
  1967年   1篇
排序方式: 共有602条查询结果,搜索用时 15 毫秒
21.
22.
Sustainable composites comprising scraps of high-density polyethylene (HDPE) and gypsum waste in proportions HDPE/gypsum 100/0, 50/50, 40/60, and 30/70 wt% were prepared. The morphology of the injected specimens was core-shell. Thermal, flammability, water absorption, and compression resistance were also evaluated. Progressively, the presence of gypsum increased the HDPE crystallinity and Tonset. Concerning the flammability, the composite 30/70 exhibited the burning rate three times lower than HDPE, indicating that the gypsum played a role as a flame retardant. The HDPE acted as waterproofing for gypsum. The compression resistance of the composites was similar to HDPE.  相似文献   
23.
24.
Roflumilast is a phosphodiesterase type 4 inhibitor that is administered orally as a long-term, in the clinical treatment of chronic obstructive pulmonary disease and asthma. Launched in 2010 for the European market, it currently does not have an official monograph. Here, a reproducible gradient RP-HPLC method was developed and validated for the separation and determination of Roflumilast in the presence of its six major degradation products. Separation was performed on a C18 analytical column (250?×?4.6?mm, 5?µm) with a mobile phase-A of ACN and a phase-B of ammonium acetate buffer (5?mM, pH 4.2) containing triethylamine (0.5% v/v). The most effective RP-HPLC gradient program was determined to be 0/80, 35/10, 36/80, 40/80 (time in minutes/% mobile phase-B). The flow rate was 1.0?ml/min and the column temperature was 25°C. The success of separation of the degradation products with different chemical characteristics was obtained by extending the time of the gradient, changing the proportion of the mobile phases and increasing the velocity of the flow. Two detectors were evaluated for the identification of degradation products and Roflumilast: a diode-arrary detector and a charged aerosol detector. The inability of the charged aerosol detector to dectect one of the six degradation products indicated that the method developed with RP-HPLC and the diode-array detector was more suitable for Roflumilast analysis. The method was validated according to specificity, linearity, LOD, LOQ, accuracy, precision and robustness.  相似文献   
25.
Despite all the attempts to create advanced hemoglobin (Hb)‐based oxygen carriers (HBOCs) employing an encapsulation platform, major challenges including attaining a high Hb loading and long circulation times still need to be overcome. Herein, the fabrication, for the first time, of nanoparticles fully made of Hb (Hb‐NPs) employing the electrospray technique is reported. The Hb‐NPs are then coated by antioxidant and self‐polymerized poly(dopamine) (PDA) to minimize the conversion of Hb into nonfunctional methemoglobin (metHb). The PDA shell is further functionalized with poly(ethylene glycol) (PEG) to achieve stealth properties. The results demonstrate that the as‐prepared Hb‐NPs are hemo‐ and biocompatible while offering antioxidant protection and decreasing the formation of metHb. Additionally, decoration with PEG results in decreased protein adsorption onto the Hb‐NPs surface, suggesting a prolonged retention time within the body. Finally, the Hb‐NPs also preserve the reversible oxygen‐binding and releasing properties of Hb. All in all, within this study, a novel HBOCs with high Hb content is fabricated and its potential as an artificial blood substitute is evaluated.  相似文献   
26.
27.
A novel application of the highly stable niobium oxide phosphate (NbOPO4) as an efficient catalyst for the synthesis of β-enamino ketones under solvent-free conditions is described. This protocol, exhibits attractive yields, short reaction periods, lower loading of catalyst and high chemoselectivity.  相似文献   
28.
Ce(OTf)3 was successfully employed as catalyst for the activation of the hydroxyl group in the Friedel–Crafts reaction of aromatic compounds with propargylic alcohols in nitromethane. The products were obtained in good to excellent yields.  相似文献   
29.
A rapid, sensitive and specific method for quantifying piracetam in human plasma using Piracetam d‐8 as the internal standard (IS) is described. The analyte and the IS were extracted from plasma by one‐step precipitation of protein using an acetonitrile (100%). The extracts were analyzed by high‐performance liquid chromatography coupled with electrospray tandem mass spectrometry (HPLC‐MS/MS). The method had a chromatographic run time of 3.8 min and a linear calibration curve over the range 0.5–50 µg/mL (r > 0.99). This LC‐MS‐MS procedure was used to assess the bioavailability of two piracetam formulations: piracetam + l‐carnitine (Piracar®; 270/330 mg tablet) and piracetam (Nootropil®; 800 mg tablet) in healthy volunteers of both sexes. The geometric means with corresponding 90% confidence interval (CI) for test/reference percentage ratios were 88.49% (90% CI = 81.19 – 96.46) for peak concentration/dose and 102.55% (90% CI = 100.62 – 104.51) for AUCinf/dose. The limit of quantitation of 0.5 µg/mL is well suited for pharmacokinetic studies in healthy volunteers. It was concluded that piracetam (Piracar®; 270/330 mg tablet) has a bioavailability equivalent to the piracetam (Nootropil®; 800 mg tablet) formulation with regard to both the rate and the extent of absorption. Copyright © 2015 John Wiley & Sons, Ltd.  相似文献   
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号